Delta-Fly Pharma (TSE:4598) Ending Cash Position: 円0.00 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:4598 Delta-Fly Pharma Inc TSE:4598
26 GF Score
Price 円154.00
! 2 Warning Signs
View Full Analysis

What is Delta-Fly Pharma Ending Cash Position?

Delta-Fly Pharma TSE:4598 +48.08% 26 Ending Cash Position is 円0.00 Mil as of Mar. 2026. GuruFocus rates TSE:4598 with a GF Score™ of 26/100. The stock has 2 warning signs investors should review.

Delta-Fly Pharma's Ending Cash Position for the quarter that ended in Mar. 2026 was 円0.00 Mil.

Delta-Fly Pharma's annual Ending Cash Position declined from Mar. 2024 (円1,417.06 Mil) to Mar. 2025 (円338.83 Mil) and declined from Mar. 2025 (円338.83 Mil) to Mar. 2026 (円145.45 Mil).

Delta-Fly Pharma Ending Cash Position Related Terms

Delta-Fly Pharma Ending Cash Position Historical Data

* Premium members only.

The historical data trend for Delta-Fly Pharma's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Delta-Fly Pharma Ending Cash Position Chart

Delta-Fly Pharma Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Ending Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,268.49 844.34 1,417.06 338.83 145.45

Delta-Fly Pharma Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Mar25 Jun25 Sep25 Dec25 Mar26
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
TSE:4598
26GF Score
Delta-Fly Pharma Inc TSE:4598
Ending Cash Position is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Delta-Fly Pharma Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Delta-Fly Pharma's Ending Cash Position for the fiscal year that ended in Mar. 2026 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=338.829+-193.376
=145.45

Delta-Fly Pharma's Ending Cash Position for the quarter that ended in Mar. 2026 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=0+0
=0.00

Frequently Asked Questions Learn more about Ending Cash Position →
What does a Ending Cash Position of 円0.00 Mil mean?
Delta-Fly Pharma (TSE:4598) has a Ending Cash Position of 円0.00 Mil as of Mar. 2026. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on Delta-Fly Pharma and its competitors.
Is Delta-Fly Pharma's Ending Cash Position too high?
Delta-Fly Pharma's current Ending Cash Position is 円0.00 Mil. Overall, Delta-Fly Pharma has a GF Score™ of 26/100, reflecting its overall financial health beyond just this single metric.
How does Delta-Fly Pharma's Ending Cash Position compare to VRTX and REGN?
Delta-Fly Pharma's Ending Cash Position of 円0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Ending Cash Position for a Biotechnology company?
A good Ending Cash Position depends on the Biotechnology industry context. However, Ending Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Ending Cash Position mean?
A high Ending Cash Position can signal that a stock is expensive relative to its fundamentals. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on Delta-Fly Pharma and its competitors. Delta-Fly Pharma's current Ending Cash Position is 円0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Delta-Fly Pharma stock overvalued right now?
Delta-Fly Pharma (TSE:4598) has a current Ending Cash Position of 円0.00 Mil. The current Ending Cash Position is 円0.00 Mil. Delta-Fly Pharma's overall GF Score™ is 26/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Ending Cash Position calculated?
Ending Cash Position is calculated from a company's financial statements. For Delta-Fly Pharma (TSE:4598), the current Ending Cash Position is 円0.00 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Delta-Fly Pharma Business Description

Address 37-5, Miyajima Nishikino, Kawauchi-cho, Tokushima, JPN, 771-0116
Delta-Fly Pharma Inc is a Japan-based company mainly engaged in the discovery and development of gentle anti-cancer agents with module technology.
26GF Score

Get the complete analysis for TSE:4598

Ending Cash Position is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円154.00
Price